• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND TALENT OCCLUDER; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND TALENT OCCLUDER; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number OCL12US
Medical Device Problem Codes Leak/Splash (1354); Difficult to Remove (1528); Malposition of Device (2616)
Health Effect - Clinical Code Injury (2348)
Date of Event 04/17/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii aui stent graft system and a talent occluder were implanted in a patient for the endovascular treatment of a 5.7 cm in diameter abdominal aortic aneurysm.The vessel morphology was reported as very tight and calcified aortic bifurcation.The right iliac artery measured between 6 mm and 7 mm in diameter.The left iliac artery measured from between 4 mm and 5 mm in diameter to between 5 mm and 6 mm in diameter.The proximal aortic neck measured 24 mm in diameter.There was severe left iliac calcification.There was moderate to severe right iliac calcification.There was mild calcification at the proximal aortic neck.The patient had a wide and conical proximal aortic neck.The left renal artery was the lowest renal artery and the right renal artery was atrophic.It was reported that endurant aui was advanced up to the left renal stent.The endurant aui was initially deployed and implanted at the intended landing zone.However, when the delivery system was being removed, there were difficulties removing the delivery system.The graft cover was below the area of calcified/tight aorta and the spindle and taper tip could not be retracted back to the graft cover.The physician advanced the delivery system above the renal arteries and could reseat the taper/spindle to the graft cover and the delivery system removed from the patient.During the manipulation of the delivery catheter the endurant aui was inadvertently pulled down.An angiogram revealed an unknown endoleak either type ia endoleak or type iv endoleak.The physician elected implant an endurant aortic cuff, without confirming the type of endoleak due to the patient¿s creatinine level of 1.6.The final angiogram showed no endoleak present.It was reported that the talent occluder device was advanced attempting to get close to the left internal iliac artery.The talent occluder was deployed and an angiogram from the sheath was performed.The angiogram revealed the talent occluder was too close to the origin of the left internal iliac artery.The physician wanted to push the talent occluder slightly proximal.The physician was inadvertently handed the talent occluder tapered tip dilator instead of a blunt tip dilator.The talent occluder taper tipped dilator was advanced through the sheath and when it exited the sheath the taper tipped dilator exited the distal common iliac artery.A retrograde angiogram demonstrated contrast outside the vessel due to vessel perforation.The physician implanted a 10mm coil distal to the talent occluder device however there was still contrast extravasation outside the vessel.The physician made the decision to cover the left internal artery with a 10mm talent occluder and the vessel perforation was covered.Per the physician, the cause of the removal difficulties resulting in stent graft movement and type ia endoleak was due to patient anatomy.Per the physician, the cause of the vessel perforation was due to user error, the wrong part was given to the physician.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Corrected information: sex, date of birth.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TALENT OCCLUDER
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key6557392
Report Number2953200-2017-00764
Device Sequence Number749652
Product Code MIH
UDI-Device Identifier00613994573148
UDI-Public00613994573148
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/14/2019
Device Model NumberOCL12US
Device Catalogue NumberOCL12US
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 04/17/2017
Supplement Date Received by Manufacturer04/17/2017
Initial Report FDA Received Date05/10/2017
Supplement Report FDA Received Date10/03/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
-
-